Intrinsic value of Molina Healthcare - MOH

Previous Close

$66.59

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$66.59

 
Intrinsic value

$213.57

 
Up/down potential

+221%

 
Rating

str. buy

 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of MOH stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 3.8

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  25.42
  17.10
  15.89
  14.80
  13.82
  12.94
  12.14
  11.43
  10.79
  10.21
  9.69
  9.22
  8.80
  8.42
  8.08
  7.77
  7.49
  7.24
  7.02
  6.82
  6.63
  6.47
  6.32
  6.19
  6.07
  5.97
  5.87
  5.78
  5.70
  5.63
  5.57
Revenue, $m
  17,782
  20,823
  24,131
  27,703
  31,532
  35,612
  39,937
  44,502
  49,302
  54,336
  59,599
  65,094
  70,820
  76,782
  82,982
  89,428
  96,128
  103,089
  110,324
  117,844
  125,662
  133,794
  142,255
  151,063
  160,236
  169,794
  179,759
  190,152
  200,998
  212,321
  224,147
Variable operating expenses, $m
 
  20,250
  23,458
  26,921
  30,633
  34,588
  38,781
  43,207
  47,861
  52,741
  57,844
  63,109
  68,661
  74,441
  80,452
  86,702
  93,197
  99,946
  106,961
  114,251
  121,831
  129,715
  137,918
  146,457
  155,351
  164,618
  174,279
  184,355
  194,870
  205,848
  217,313
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  17,476
  20,250
  23,458
  26,921
  30,633
  34,588
  38,781
  43,207
  47,861
  52,741
  57,844
  63,109
  68,661
  74,441
  80,452
  86,702
  93,197
  99,946
  106,961
  114,251
  121,831
  129,715
  137,918
  146,457
  155,351
  164,618
  174,279
  184,355
  194,870
  205,848
  217,313
Operating income, $m
  306
  573
  674
  783
  899
  1,024
  1,156
  1,295
  1,441
  1,595
  1,755
  1,984
  2,159
  2,341
  2,530
  2,726
  2,931
  3,143
  3,363
  3,593
  3,831
  4,079
  4,337
  4,605
  4,885
  5,176
  5,480
  5,797
  6,128
  6,473
  6,833
EBITDA, $m
  488
  739
  856
  983
  1,119
  1,264
  1,417
  1,579
  1,750
  1,928
  2,115
  2,310
  2,513
  2,725
  2,945
  3,174
  3,411
  3,658
  3,915
  4,182
  4,459
  4,748
  5,048
  5,361
  5,686
  6,025
  6,379
  6,748
  7,133
  7,535
  7,954
Interest expense (income), $m
  66
  48
  -46
  -27
  -5
  18
  42
  68
  95
  123
  153
  185
  218
  252
  287
  324
  363
  402
  444
  487
  532
  579
  627
  677
  730
  785
  842
  901
  963
  1,027
  1,095
Earnings before tax, $m
  205
  525
  720
  809
  905
  1,006
  1,114
  1,227
  1,346
  1,471
  1,602
  1,800
  1,942
  2,089
  2,243
  2,402
  2,568
  2,740
  2,919
  3,106
  3,299
  3,500
  3,710
  3,928
  4,155
  4,392
  4,639
  4,896
  5,165
  5,445
  5,739
Tax expense, $m
  153
  142
  194
  218
  244
  272
  301
  331
  363
  397
  432
  486
  524
  564
  606
  649
  693
  740
  788
  839
  891
  945
  1,002
  1,061
  1,122
  1,186
  1,252
  1,322
  1,395
  1,470
  1,549
Net income, $m
  52
  383
  526
  591
  660
  734
  813
  896
  983
  1,074
  1,169
  1,314
  1,417
  1,525
  1,637
  1,754
  1,875
  2,000
  2,131
  2,267
  2,408
  2,555
  2,708
  2,867
  3,033
  3,206
  3,386
  3,574
  3,770
  3,975
  4,189

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  4,577
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  7,449
  3,363
  3,897
  4,474
  5,092
  5,751
  6,450
  7,187
  7,962
  8,775
  9,625
  10,513
  11,437
  12,400
  13,402
  14,443
  15,524
  16,649
  17,817
  19,032
  20,294
  21,608
  22,974
  24,396
  25,878
  27,422
  29,031
  30,709
  32,461
  34,290
  36,199
Adjusted assets (=assets-cash), $m
  2,872
  3,363
  3,897
  4,474
  5,092
  5,751
  6,450
  7,187
  7,962
  8,775
  9,625
  10,513
  11,437
  12,400
  13,402
  14,443
  15,524
  16,649
  17,817
  19,032
  20,294
  21,608
  22,974
  24,396
  25,878
  27,422
  29,031
  30,709
  32,461
  34,290
  36,199
Revenue / Adjusted assets
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
Average production assets, $m
  555
  646
  748
  859
  977
  1,104
  1,238
  1,380
  1,528
  1,684
  1,848
  2,018
  2,195
  2,380
  2,572
  2,772
  2,980
  3,196
  3,420
  3,653
  3,896
  4,148
  4,410
  4,683
  4,967
  5,264
  5,573
  5,895
  6,231
  6,582
  6,949
Working capital, $m
  1,418
  -3,144
  -3,644
  -4,183
  -4,761
  -5,377
  -6,030
  -6,720
  -7,445
  -8,205
  -9,000
  -9,829
  -10,694
  -11,594
  -12,530
  -13,504
  -14,515
  -15,566
  -16,659
  -17,794
  -18,975
  -20,203
  -21,481
  -22,810
  -24,196
  -25,639
  -27,144
  -28,713
  -30,351
  -32,060
  -33,846
Total debt, $m
  1,645
  -1,128
  -648
  -128
  428
  1,021
  1,650
  2,313
  3,011
  3,743
  4,508
  5,306
  6,139
  7,005
  7,906
  8,843
  9,817
  10,829
  11,880
  12,973
  14,110
  15,292
  16,522
  17,802
  19,135
  20,524
  21,973
  23,483
  25,060
  26,706
  28,424
Total liabilities, $m
  5,800
  3,027
  3,507
  4,027
  4,583
  5,176
  5,805
  6,468
  7,166
  7,898
  8,663
  9,461
  10,294
  11,160
  12,061
  12,998
  13,972
  14,984
  16,035
  17,128
  18,265
  19,447
  20,677
  21,957
  23,290
  24,679
  26,128
  27,638
  29,215
  30,861
  32,579
Total equity, $m
  1,649
  336
  390
  447
  509
  575
  645
  719
  796
  878
  963
  1,051
  1,144
  1,240
  1,340
  1,444
  1,552
  1,665
  1,782
  1,903
  2,029
  2,161
  2,297
  2,440
  2,588
  2,742
  2,903
  3,071
  3,246
  3,429
  3,620
Total liabilities and equity, $m
  7,449
  3,363
  3,897
  4,474
  5,092
  5,751
  6,450
  7,187
  7,962
  8,776
  9,626
  10,512
  11,438
  12,400
  13,401
  14,442
  15,524
  16,649
  17,817
  19,031
  20,294
  21,608
  22,974
  24,397
  25,878
  27,421
  29,031
  30,709
  32,461
  34,290
  36,199
Debt-to-equity ratio
  0.998
  -3.360
  -1.660
  -0.290
  0.840
  1.780
  2.560
  3.220
  3.780
  4.270
  4.680
  5.050
  5.370
  5.650
  5.900
  6.120
  6.320
  6.500
  6.670
  6.820
  6.950
  7.080
  7.190
  7.300
  7.390
  7.480
  7.570
  7.650
  7.720
  7.790
  7.850
Adjusted equity ratio
  -1.019
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  52
  383
  526
  591
  660
  734
  813
  896
  983
  1,074
  1,169
  1,314
  1,417
  1,525
  1,637
  1,754
  1,875
  2,000
  2,131
  2,267
  2,408
  2,555
  2,708
  2,867
  3,033
  3,206
  3,386
  3,574
  3,770
  3,975
  4,189
Depreciation, amort., depletion, $m
  182
  166
  183
  201
  220
  240
  262
  285
  309
  334
  360
  325
  354
  384
  415
  447
  481
  515
  552
  589
  628
  669
  711
  755
  801
  849
  899
  951
  1,005
  1,062
  1,121
Funds from operations, $m
  1,017
  549
  708
  791
  880
  975
  1,075
  1,180
  1,291
  1,408
  1,529
  1,639
  1,771
  1,909
  2,052
  2,201
  2,355
  2,516
  2,683
  2,856
  3,037
  3,224
  3,420
  3,623
  3,834
  4,055
  4,285
  4,525
  4,775
  5,037
  5,310
Change in working capital, $m
  344
  -459
  -500
  -539
  -578
  -616
  -653
  -689
  -725
  -760
  -795
  -830
  -865
  -900
  -936
  -973
  -1,012
  -1,051
  -1,092
  -1,135
  -1,181
  -1,228
  -1,278
  -1,330
  -1,385
  -1,443
  -1,505
  -1,569
  -1,638
  -1,710
  -1,786
Cash from operations, $m
  673
  1,048
  1,208
  1,331
  1,458
  1,591
  1,728
  1,870
  2,016
  2,168
  2,324
  2,469
  2,636
  2,809
  2,988
  3,174
  3,367
  3,567
  3,775
  3,992
  4,217
  4,452
  4,697
  4,953
  5,220
  5,498
  5,790
  6,094
  6,413
  6,747
  7,096
Maintenance CAPEX, $m
  0
  -89
  -104
  -121
  -139
  -158
  -178
  -200
  -223
  -247
  -272
  -298
  -325
  -354
  -384
  -415
  -447
  -481
  -515
  -552
  -589
  -628
  -669
  -711
  -755
  -801
  -849
  -899
  -951
  -1,005
  -1,062
New CAPEX, $m
  -176
  -91
  -103
  -111
  -119
  -126
  -134
  -142
  -149
  -156
  -163
  -170
  -178
  -185
  -192
  -200
  -208
  -216
  -224
  -233
  -242
  -252
  -262
  -273
  -284
  -296
  -309
  -322
  -336
  -351
  -367
Cash from investing activities, $m
  -202
  -180
  -207
  -232
  -258
  -284
  -312
  -342
  -372
  -403
  -435
  -468
  -503
  -539
  -576
  -615
  -655
  -697
  -739
  -785
  -831
  -880
  -931
  -984
  -1,039
  -1,097
  -1,158
  -1,221
  -1,287
  -1,356
  -1,429
Free cash flow, $m
  471
  867
  1,001
  1,099
  1,201
  1,306
  1,416
  1,528
  1,645
  1,765
  1,889
  2,001
  2,133
  2,270
  2,412
  2,559
  2,712
  2,871
  3,036
  3,207
  3,386
  3,572
  3,766
  3,968
  4,180
  4,401
  4,632
  4,873
  5,126
  5,391
  5,667
Issuance/(repayment) of debt, $m
  0
  -2,301
  481
  519
  557
  593
  629
  664
  698
  732
  765
  799
  832
  866
  901
  937
  974
  1,012
  1,052
  1,093
  1,136
  1,182
  1,230
  1,280
  1,333
  1,389
  1,448
  1,511
  1,576
  1,646
  1,719
Issuance/(repurchase) of shares, $m
  18
  121
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  19
  -2,180
  481
  519
  557
  593
  629
  664
  698
  732
  765
  799
  832
  866
  901
  937
  974
  1,012
  1,052
  1,093
  1,136
  1,182
  1,230
  1,280
  1,333
  1,389
  1,448
  1,511
  1,576
  1,646
  1,719
Total cash flow (excl. dividends), $m
  490
  -1,434
  1,482
  1,618
  1,757
  1,899
  2,044
  2,192
  2,343
  2,497
  2,654
  2,799
  2,965
  3,137
  3,313
  3,496
  3,686
  3,883
  4,087
  4,300
  4,522
  4,754
  4,996
  5,249
  5,513
  5,790
  6,080
  6,384
  6,702
  7,036
  7,386
Retained Cash Flow (-), $m
  -92
  -2,792
  -53
  -58
  -62
  -66
  -70
  -74
  -78
  -81
  -85
  -89
  -92
  -96
  -100
  -104
  -108
  -112
  -117
  -121
  -126
  -131
  -137
  -142
  -148
  -154
  -161
  -168
  -175
  -183
  -191
Prev. year cash balance distribution, $m
 
  4,105
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  0
  1,429
  1,561
  1,696
  1,834
  1,974
  2,118
  2,265
  2,415
  2,569
  2,710
  2,873
  3,040
  3,213
  3,392
  3,578
  3,770
  3,970
  4,179
  4,396
  4,622
  4,859
  5,106
  5,365
  5,636
  5,919
  6,216
  6,527
  6,853
  7,195
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  0
  1,308
  1,358
  1,396
  1,421
  1,433
  1,431
  1,416
  1,387
  1,347
  1,287
  1,226
  1,156
  1,079
  996
  909
  820
  731
  643
  559
  478
  403
  335
  273
  219
  173
  133
  101
  75
  54
Current shareholders' claim on cash, %
  100
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program. The company operates through three segments: Health Plans, Molina Medicaid Solutions, and Other. The Health Plans segment operates health plans in 11 states. As of December 31, 2015, this segment served approximately 3.5 million members who were eligible for Medicaid, Medicare, and other government-sponsored health care programs. The Molina Medicaid Solutions segment provides design, development, implementation; business process outsourcing; hosting services; and information technology development and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well as the U.S. Virgin Islands; and drug rebate administration services in Florida. The Other segment provides behavioral health and social services. The company offers health care services for its members through contracts with independent physicians and groups; hospitals; and ancillary providers, as well as through its clinics. Molina Healthcare, Inc. was founded in 1980 and is headquartered in Long Beach, California.

FINANCIAL RATIOS  of  Molina Healthcare (MOH)

Valuation Ratios
P/E Ratio 73
Price to Sales 0.2
Price to Book 2.3
Price to Tangible Book
Price to Cash Flow 5.6
Price to Free Cash Flow 7.6
Growth Rates
Sales Growth Rate 25.4%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 33.3%
Cap. Spend. - 3 Yr. Gr. Rate 12.4%
Financial Strength
Quick Ratio 10
Current Ratio 0.1
LT Debt to Equity 71.1%
Total Debt to Equity 99.8%
Interest Coverage 4
Management Effectiveness
Return On Assets 1%
Ret/ On Assets - 3 Yr. Avg. 2%
Return On Total Capital 1.6%
Ret/ On T. Cap. - 3 Yr. Avg. 3.6%
Return On Equity 3.2%
Return On Equity - 3 Yr. Avg. 7%
Asset Turnover 2.5
Profitability Ratios
Gross Margin 14.2%
Gross Margin - 3 Yr. Avg. 14.8%
EBITDA Margin 2.5%
EBITDA Margin - 3 Yr. Avg. 3%
Operating Margin 1.7%
Oper. Margin - 3 Yr. Avg. 2.1%
Pre-Tax Margin 1.2%
Pre-Tax Margin - 3 Yr. Avg. 1.6%
Net Profit Margin 0.3%
Net Profit Margin - 3 Yr. Avg. 0.6%
Effective Tax Rate 74.6%
Eff/ Tax Rate - 3 Yr. Avg. 61.2%
Payout Ratio 0%

MOH stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MOH stock intrinsic value calculation we used $17782 million for the last fiscal year's total revenue generated by Molina Healthcare. The default revenue input number comes from 2016 income statement of Molina Healthcare. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MOH stock valuation model: a) initial revenue growth rate of 17.1% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for MOH is calculated based on our internal credit rating of Molina Healthcare, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Molina Healthcare.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MOH stock the variable cost ratio is equal to 97.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for MOH stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 4.1% for Molina Healthcare.

Corporate tax rate of 27% is the nominal tax rate for Molina Healthcare. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MOH stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MOH are equal to 3.1%.

Life of production assets of 6.2 years is the average useful life of capital assets used in Molina Healthcare operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MOH is equal to -15.1%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $1649 million for Molina Healthcare - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 56.798 million for Molina Healthcare is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Molina Healthcare at the current share price and the inputted number of shares is $3.8 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
CNC Centene 74.75 prem.  prem.
WCG WellCare Healt 172.07 prem.  prem.
AET Aetna 143.94 prem.  prem.
ANTM Anthem 180.08 prem.  prem.
GTS Triple-S Manag 16.34 prem.  prem.
UNH UnitedHealth G 175.59 prem.  prem.
MGLN Magellan Healt 70.20 prem.  prem.
HUM Humana 231.61 prem.  prem.
UAM Universal Amer 9.97 prem.  prem.

COMPANY NEWS

▶ UPDATE: When Molina layoffs will go into effect   [May-10-17 09:31AM  American City Business Journals]
▶ Buy This Insurer Instead of Molina Health   [May-04-17 04:41PM  Motley Fool]
▶ Leadership shakeup rocks Molina Healthcare's national C-suite   [May-03-17 05:22PM  American City Business Journals]
▶ [$$] Molina Healthcare Fires CEO, CFO   [12:28AM  The Wall Street Journal]
▶ [$$] Molina Healthcare Fires CEO, CFO   [May-02-17 07:36PM  The Wall Street Journal]
▶ Molina beats Street 1Q forecasts   [05:58PM  Associated Press]
▶ Fast Money Final Trade: YHOO, MOH & more   [05:58PM  CNBC Videos]
▶ Big ObamaCare Insurer Molina Health Fires CEO; Stock Surges   [04:43PM  Investor's Business Daily]
▶ Molina Health fires CEO, CFO   [01:22PM  CNBC Videos]
▶ Molina Healthcare Might Leave Obamacare in 2018   [Apr-27-17 04:30PM  TheStreet.com]
▶ Insurer Anthem hands feds deadline on crucial ACA subsidies   [Apr-26-17 01:59PM  Associated Press]
▶ New Strong Sell Stocks for April 19th   [Apr-19-17 08:06AM  Zacks]
▶ High-profile NM health care leader resigns   [Apr-13-17 01:25PM  American City Business Journals]
▶ [$$] Aetna to Exit Iowa's ACA Marketplace   [Apr-06-17 04:39PM  The Wall Street Journal]
▶ 3 Stocks to Buy As Obamacare Collapses   [Mar-05-17 02:03PM  at Motley Fool]
▶ 10 Biggest HMOs in USA   [Feb-21-17 04:30PM  at Insider Monkey]
Stock chart of MOH Financial statements of MOH Annual reports of MOH
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.